787
Participants
Start Date
April 29, 2025
Primary Completion Date
December 31, 2028
Study Completion Date
December 31, 2028
Azithromycin
Azithromycin 500 milligrams intravenously once and cefazolin 2 grams intravenously every 8 hours for up to three doses
Placebo
Placebo given in place of other two active drugs
RECRUITING
University of Oklahoma Health Sciences Center, Oklahoma City
Collaborators (1)
University of Alabama at Birmingham
OTHER
University of Florida
OTHER
Duke University
OTHER
Case Western Reserve University
OTHER
University of Oklahoma
OTHER